Company Overview
MEREO BIOPHARMA GROUP PLC
MREORevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
1M
2025 FY
Net Income
-42M
2025 FY
Shares Outstanding
797M
2025 FY
EPS
-0.05USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1719714
Exchange
Nasdaq
Location
GB